A closer look at the coverage of the AlphaFold Human Proteome

In this post of our AlphaFold Series, we look at the gaps in proteome coverage addressed by...

CONTINUE READING

AlphaFold 2: What No One Is Talking About

In this next installment of our AlphaFold Series, we look at the potential drawbacks and...

CONTINUE READING

Building Good Partnerships

At my job, I was frequently asked by external parties what I meant by saying, “Cyclica is a drug...

CONTINUE READING

Cyclica successfully integrates DeepMind’s AlphaFold 2

AlphaFold 2 has provided structures for a large percentage of the proteome, perfectly complementary...

CONTINUE READING

Machine Learning - Groups are collections of similar individuals

Did you notice in a conference room or event, people are grouped based on their similarities? They...

CONTINUE READING

Full Speed Ahead: What DeepMind’s Newest Revelation means for Scientific/Research Advancement

Last Week, DeepMind announced on their blog that they had made available, in collaboration with...

CONTINUE READING

Machine Learning - Less is enough

We don’t need to know everything for decision-making. When doctors assess if a patient is obese or...

CONTINUE READING

Quantum Computing in Drug Discovery: Myth and Reality

What is quantum computing?

CONTINUE READING

Drug Repurposing for COVID19: What has been done, and how we're tackling it.

Originally published on LinkedIn: https://bit.ly/3EqDDeN

Over the past few weeks, we’ve strategized...

CONTINUE READING

Machine Learning: Learning beyond living things

Industrial revolutions throughout history can be defined as pivotal stages in an advancing society,...

CONTINUE READING